In obesity, hyperglycemia, and insulin-resistant states, VSMCs undergo phenotypic changes marked by increased proliferation, migration, cell cycle progression, and transformation into inflammatory and osteoblastic phenotypes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.